Gronghui APP was informed that according to the latest equity disclosure information of the Stock Exchange, from June 22 to June 24, 2022, East Rui Pharmaceutical (02348.HK) was increased by non-executive director Liang Kangmin at an average price of HK $1.22 to HK $1.2812 per share, involving a capital of about HK $1.3667 million.

After the increase, Liang Kangmin's latest number of shares is 106612000 shares, with the proportion of shares rising from 7.04% to 7.11%.